ABSTRACT
INTRODUCTION
Single nucleotide polymorphisms (SNPs) are the most abundant form of genetic variation, accounting for approximately 90% of the DNA polymorphism in humans (Collins et al., 1998) . It is estimated that there is a SNP of greater than 1% frequency for every 290 base-pairs (Kruglyak and Nickerson, 2001 ). Within coding regions there are on average 4 SNPs per gene with a frequency above 1%. About half of these cause amino acid substitutions: termed non-synonymous SNPs (nsSNPs) (Cargill et al., 1999) .
Deleterious SNP prediction tries to ascertain if an nsSNP will affect a protein's function and possibly contribute to genetic disease. Methods in the existing literature have used a large range of structure-and sequence-based attributes to separate deleterious from neutral SNPs (see supplementary Tables 1 and 2 for information). Structural attributes provide more understanding of effect mechanisms, but are not available for all SNPs. Sequence attributes usually identify important residues using information from homologous proteins. With enough homologues (∼10), * To whom correspondence should be addressed. Abbreviations: AA, amino-acid; DT, decision trees; HEAT, human expected amino-acid transitions; MNM, multiple nucleotide mutations; nsSNP non-synonymous SNP; OE, overall error; PSSM, position specific scoring matrix; SAP, single amino-acid polymorphism; SI, sequence identity; SNP, single nucleotide polymorphism.
sequence attributes can often compete effectively with structural approaches (Saunders and Baker, 2002; Bao and Cui, 2005; Yue and Moult, 2006) .
Efforts to classify SNPs have used these attributes in a variety of prediction methods from sets of empirical rules (Ng and Henikoff, 2001; Sunyaev et al., 2001; Wang and Moult, 2001; Ramensky et al., 2002; Herrgard et al., 2003) , probabilistic prediction (Chasman and Adams, 2001 ) to a variety of machine learning techniques including decision trees (Krishnan and Westhead, 2003; Dobson et al., 2006) , support vector machines (Krishnan and Westhead, 2003; Bao and Cui, 2005; Yue et al., 2005; Yue and Moult, 2006) , neural networks (Ferrer-Costa et al., 2004; Ferrer-Costa et al., 2005) , Bayesian networks (Cai et al., 2004; Needham et al., 2006) , random forests (Bao and Cui, 2005) and Bayesian multivariate adaptive regression splines (Verzilli et al., 2005) . Although these different approaches derive prediction rules in a variety of ways they almost all require a data set of classified mutations for both model building (training) and error rate estimation (validation). For machine learning methods to generalize well to target data, it is imperative that the right training data is chosen; the training and validation data should be drawn from the same (usually unknown) distribution as the target data.
However, this is not easy to arrange for the problem concerned, and a number of very different data sets have been employed. Some workers have used deleterious and neutral nsSNPs data based on systematic mutation studies on particular proteins (Chasman and Adams, 2001; Ng and Henikoff, 2001; Wang and Moult, 2001; Krishnan and Westhead, 2003; Cai et al., 2004; Verzilli et al., 2005) . Others have used annotated disease variants from protein sequence databases as deleterious data, and have generated neutral data sets either from annotated sequence variants not known to be associated with disease (Bao and Cui, 2005) , or by using pseudo mutations between orthologous proteins in closely related species (Sunyaev et al., 2001; Ferrer-Costa et al., 2002; Ramensky et al., 2002; Ferrer-Costa et al., 2004; Ferrer-Costa et al., 2005; Yue et al., 2005; Yue and Moult, 2006) . These approaches yield data sets that are different in content and character, with different properties when used to train machine learning methods, and give rise to classifiers with varying error rates.
This paper is the first attempt to quantify the above effects. We begin by comparing the contents of the data sets to what might be expected in the target prediction data (real human SNPs). Then, using a simple decision tree method to produce easily interpretable classifiers, we study the relationships between data set, classifiers and estimated accuracy. Finally, we quantify the transferability of classifiers between data sets, thus quantifying the effect of, for instance, training a method on systematic mutagenesis data and applying it to human SNPs. This leads to detailed understanding of the advantages and potential pitfalls of each data set in training and validating nsSNP prediction methods.
SYSTEMS AND METHODS

Decision trees
Decision trees (DT) are predictive models, displayed as a top down tree structure. Every node in the tree represents a decision point, where a test is carried out upon an attribute. For every possible outcome of the test there will be a child node, until the final decision node is reached, which branches to a set of leaf nodes giving the final classification. Here, we used the "yet another decision tree" (YaDT) algorithm (Ruggieri, 2004) for constructing trees, using default parameters (confidence cut-off of 0.5; accepting all predictions) and with no optimisation.
Evaluation of accuracy
All experiments were carried out multiple times (see cross-validation section) with balanced data sets using evaluation measures including the overall error ( 
Data sets
Three different types of data set were used for deleterious SNP prediction, shown in Table 1 (see supplementary Table 3 for information on data set usage in other studies, and Table 4 for detailed information on data sets used here):
Mutagenesis data sets The mutagenesis data sets consist of systematic unbiased mutations of the T4 lysozyme (Alber et al., 1987; Rennell et al., 1991) and lac repressor (Markiewicz et al., 1994; Suckow et al., 1996) proteins. The subset of mutations used here (from Krishnan and Westhead, 2003) has 1990 mutations for the T4 lysozyme and 3303 for the lac repressor protein. The original mutagenesis experiments classified each mutation into four effect categories which were reduced to a binary classification by Chasman and Adams (2001) , yielding data sets with 40% and 38% of deleterious mutations for the lac and lysozyme respectively.
Swiss-Prot data set
Another type of data set used for deleterious SNP prediction is derived from the Swiss-Prot variant webpage (Yip et al., 2004) . Approximately 20% of the human proteins contained in the SwissProt knowledgebase have one or more single amino acid polymorphism (SAP) (Boeckmann et al., 2003) . Each SAP is manually annotated in the feature table of the Swiss-Prot variant database with the label 'disease' (SAP with disease association), 'polymorphism' (SAP with no known disease association) or 'unclassified' (SAP which has too little information to classify). Parsing this data gave a total of 12911 disease SAPs on 1055 proteins and 8302 polymorphism SAPs (deemed neutral) on 3388 proteins. Divergent data set An alternative source of neutral SAPs is the divergence data set, created by noting the changes between human proteins and their related mammalian orthologs. It is assumed that almost all of the variation fixed between closely related species is non-deleterious. There is a variation in the exact method used to create a divergent data set. Some research groups accept proteins with >90% sequence identity (SI) and >80% coverage allowing all matches per species (Yue and Moult, 2006) , whilst others only accept >95% SI over 100% coverage and to avoid paralogs only use the best match per species (Sunyaev et al., 2001) .
As is the normal practice, the proteins containing disease SAPs (SwissProt 'disease') were used to generate a divergence data set. Each protein was searched against the NCBI non-redundant (NR) database using BLASTP (Altschul et al., 1997) . All non-mammalian matches were discarded and the remaining matches processed using two different methods. For both methods each match was aligned with its corresponding disease protein and all amino acid differences were noted along with the SI of the alignment. This resulted in a set of pseudo mutations separated into SI categories from >=30% to >=95% SI. Furthermore, one of the methods used all of the mammalian matches (neutralAH) generated by BLASTP whilst the other only used the best match per mammalian species (neutralBH, as Sunyaev et al., 2001) 
Attributes
To allow for predictions to be made on all available SNPs a set of attributes was selected that could be generated without any requirement for structural information:
(1) Original and mutated amino acid residue identity (2) Original and mutated amino acid physicochemical class (Hydrophobic, Polar, Charged, Glycine) (3) Hydrophobicity difference between original and mutated residues (4) Mass shift upon mutation (5) Predicted secondary structure at mutation site:(Loop,Helix, Strand) (6) Predicted solvent accessibility at mutation site: (0→9 ; buried→exposed) (7) Scorecons value: sequence conservation score at mutation site: (0→1; not→fully conserved) (8) Buried charge at mutation site: (Residue is one of K, R, D, E, H and has an accessibility of 0 or 1) (9) PSSM value for amino acid substitution (10) Log-odds score of amino acid substitution Attributes 1-8 are the same as those used by Krishnan et al (2003) , with the exception that only predicted secondary-structure and solvent accessibility were used and these were generated using the Sable program (Adamczak et al., 2004) rather than PHD (Rost and Sander, 1993) . The attributes were generated as follows: Each protein sequence was submitted to Sable for secondary-structure and solvent accessibility prediction. Sable carries out a PSIBLAST (Altschul et al., 1997) search against the NCBI NR database with 3 iterations. The resultant alignment profile and position specific scoring matrix (PSSM) were retained for later use. The proteins in the PSIBLAST alignment profile with E-score values less than 10 -3 were pulled out of the NR database using fastacmd and then aligned with the human query protein using Muscle (Edgar, 2004) . The produced multiple alignment was submitted to Scorecons (Valdar, 2002) to calculate the sequence conservation. The log-odds score was calculated as the log ratio of amino acid substitution probabilities in the neutral and deleterious data sets respectively.
Cross-validation and data set randomisation
All data sets were sampled to give an equal number of positive and negative examples, as it has been shown that balanced data sets give the best accuracy with decision trees (Dobson et al., 2006) . For the homogeneous cross-validation experiments (training and validation data drawn from the same data set) 4000 SAPs were randomly sampled from each data set 10 times (e.g. 4000 deleterious and 4000 neutral) and used to carry out 10-fold cross-validation. To remove any possible training bias multiple SAPs on a given protein were not split between training and testing sections. In addition, the level of homologous proteins within the training data is too low to cause bias (data not shown).
Heterogeneous cross-validation involves using one data set for training and another for testing. For some of the experiments part of the training set was from the same data set type as the test set (e.g. train on disease/polymorphism, test on disease/divergent) and, therefore, the data sets had to be split into training and test groups. Thus, 4000 SAPs were randomly sampled 10 times from each data set and then split into training and test parts, as above. This gave training and test data sets of 4000 mutations (2000 deleterious and 2000 neutral).
The exception to the above regards the experiments using the mutagenesis data sets which owing to their limited size had to be sampled differently. These data sets were each initially split into the two classes of mutation (lac: 1325 'deleterious', 1978 'neutral'; lysozyme: 762 'deleterious', 1228 'neutral') . From these 762 mutations were randomly sampled 10 times from each part (maximum size limited by lysozyme 'deleterious'). These samples were then used to carry out 10-fold homogeneous cross-validation, with training and testing sizes of 1372 and 152 mutations respectively. In addition, the lac and lysozyme data sets were merged to make a combined mutagenesis data set containing 3048 mutations per sample.
Construction of HEAT matrix
A matrix of human expected amino acid transitions (HEAT) was constructed, consisting of the expected rates of amino acid substitutions in human protein coding genes, in the absence of selection. It was constructed in a similar fashion to Vitkup (Vitkup et al., 2003) using a matrix of neighbour-dependent substitution rates (Hess et al., 1994) . These rates were generated by aligning ~10 Mb of human gene-pseudogene pairs, resulting in 20,200 pseudo mutations. From this the relative substitution rates (X→Y) were calculated for the four nucleotide bases (X,Y) starting in all possible 3 nucleotide neighbourhoods (*X*), giving a matrix of 96 neighbourhood dependent substitution rates ([12 x 16]/2; 12 possible substitutions in 16 possible 3 base contexts with data aggregated for complementary substitutions) with a 65-fold variation of relative rates.
Here, we used this matrix of relative rates along with calculated average human-codon-usage to calculate the expected rates of all the amino acid substitutions resulting from single nucleotide mutations (SNM). The resulting HEAT matrix, shown in Fig. 2(A) , is based on the average codon usage across all known coding sequences in the human genome and, thus, is more general than those produced by Vitkup(2003) , which were created from a smaller sample of genes.
RESULTS
Data set comparisons
Single nucleotide mutations (SNM) within codons can give rise to 150 possible amino acid substitutions (see Fig. 2 (A) for relative rates in humans). The remaining 230 amino acid substitutions require multiple nucleotide mutations (MNM) to occur within a codon. Fig. 1 shows the percentage of amino acid substitutions in each data set that result from MNM. The two mutagenesis data sets have a very high percentage of MNM (Lac = 57%, Lyso = 59%). The Swiss-Prot data sets, in contrast, have almost no MNM with the disease and polymorphism having only 0.2% and 0.1% respectively. The divergent 'neutral' data sets have 5-40% MNM, depending on the SI threshold, a lower level than the mutagenesis data sets but still far greater than observed in the Swiss-Prot data sets.
Even with this rudimentary data set analysis, it becomes apparent that a large percentage of the mutations in the mutagenesis data sets (Lac/Lyso), and a significant proportion in the divergent data sets (neutralAH/BH), are very unlikely to be observed in the short evolutionary distance associated with real human mutations. One possible result of this is that irrelevant rules will be generated by learning methods, with significant effects on prediction accuracy (see later sections).
A more sophisticated method for comparing data sets is to observe their relative content of amino acid substitutions. Here we compare the amino acid substitution rates in each data set using HEAT as a reference distribution. Thus, the Swiss-Prot data set, consisting of human SAPs, would be expected to be similar to this distribution, with any significant differences attributable to natural selection within the human population. The divergent data sets, consisting of pseudo-mutations between man and related mammals, are also likely to be similar, but with the deviation from HEAT attributable to longer evolutionary distances.
HEAT is shown in Fig. 2(A) , displaying the expected relative rates of amino acid substitutions. The amino acids are arranged by similarity, so that substitutions lying close to the leading (top-leftto-bottom-right) diagonal are between chemically similar amino acids. The non-uniform nature of the matrix is due to a variety of factors; the differing number of codons for each amino acid, the codon usage pattern in the human genome and the high rate of mutations caused by CpG deamination in certain codons, notably Arg in which 4 of the 6 codons contain CpG sites.
The HEAT matrix only contains amino acid substitutions resulting from SNM and has no values for the other less likely amino acid substitutions (from MNM; represented by '×'). Owing to the number of MNM present in the mutagenesis data sets, they were set aside for this analysis. For the other data sets count matrices were created with the counts of all amino acid substitutions resulting from SNM.
Then, to see which substitutions were over/under represented in each data set, the logodds score was calculated for each amino acid substitution [log (P(dataset Substitution)/P(HEAT Substitution)) ]. In addition the Pearson's correlation between each data set and the HEAT matrix was calculated and is given along with an estimate of significance.
The results for three of the data sets are shown in Fig. 2 . For the Swiss-Prot disease data set (Fig. 2(B) ; r = 0.81, p < 0.0001) the squares lying close to the leading diagonal, displaying substitutions between chemically similar amino acids, are under-represented whilst those not lying close to this diagonal, substitutions between chemically dissimilar amino acids, are over-represented. For the Swiss-Prot polymorphism data set (Fig. 2(C) ; r = 0.91, p < 0.0001) there is the opposite trend, with the squares close to the leading diagonal over-represented, or near to expected, and the squares not lying close to the leading diagonal under-represented. As expected this data set is more strongly correlated with HEAT than the disease mutations.
In the Swiss-Prot disease data set ( Fig. 2(B) ) the most overrepresented substitutions are from the amino acids Cys, Gly, Trp, Arg and Tyr; this agrees with the findings of Vitkup (Vitkup et al., 2003) . The differences seen in the data sets are mainly governed by the types of substitutions an amino acid can undergo by SNM. In some cases, such as Cys and Trp, the substitutions resulting from SNM are all disfavored, while for others, such as Gly, the substitutions resulting from SNM are a mixture of favored, neutral, and disfavored. Thus, substitutions from Cys and Trp are very likely to be deleterious, not only because these amino acids play important structural roles but also because their likely substitutions are all disfavored. 3 . Effect of divergent data set's minimum sequence identity on overall error. Displaying homogeneous cross-validation overall error percent for 'All' attributes, 'AA substitution only' and 'PSSM only' with increasing sequence identity cut-off; data set disease/divergent Most of the substitutions that are over-represented in the disease data set are under-represented in the polymorphism data set (Fig. 2  (C) ) with Cys and Tyr having the strongest divergence from HEAT, suggesting that even the relatively simple attribute of amino acid substitution would separate these data sets to some extent.
The divergent (neutralBH90) data set ( Fig. 2(D) ; r = 0.74, p < 0.0001) is similar to the polymorphism, except that the divergence from HEAT is generally greater, owing to longer evolutionary distances, particularly for example with substitutions from Cys and Trp. A notable exception is Arg, which is slightly overrepresented in the polymorphism data set and strongly underrepresented in the divergent data set. In this case, substitutions over short evolutionary distances are strongly influenced by the coding sequence. As the evolutionary distance increases, selection begins to reflect the constraints imposed by protein structural stability and function, favoring substitutions between amino acids with similar chemical properties (the only over-represented substitution in this latter case is Arg to the related basic amino acid Lys) (Benner et al., 1994) .
Overall, the comparison with the HEAT matrix has highlighted differences between the data sets, showing the potential to discriminate deleterious from neutral using only the parameter of amino acid substitution. It has also emphasised significant differences in the distribution of amino acid substitutions present in the Swiss-Prot polymorphism and divergent data sets. The polymorphism data set has a high level of correlation with the HEAT matrix (r = 0.91, p < 0.0001), while the divergent data set's correlation (r = 0.74, p < 0.0001) is actually less than that of SwissProt disease (r = 0.81, p < 0.0001).
This has important consequences for machine learning methods: rules learned using the divergent data sets for neutral data are likely to give accurate rules to separate deleterious from neutral. However, there is a danger that the basis of these rules would be simply the differing evolutionary distances for the mutations in the Swiss-Prot disease set compared with the divergent data sets. Such rules may be of little use in distinguishing human disease mutations from neutral mutations occurring on the same evolutionary time scale.
Decision tree homogeneous cross-validation
The results from homogeneous 10 fold cross-validation are shown in Table 2 (see Systems and Methods for information on accuracy measures). The results are split according to the attributes used for prediction, giving a comparison of accuracy using 'All' of the attributes with that from some important individual attributes used independently ('PSSM only', position specific scoring matrix value; 'AA substitution only', amino acid substitution; 'Scorecons only', conservation value).
When 'All' attributes are used for prediction the overall-error (OE) ranges from 19.88 to 30.05 across the different data sets, showing that even under homogeneous cross-validation some data sets are far easier to classify than others. This range of accuracy across data sets is greatly influenced by the level of distinction between the "deleterious"/"neutral" parts of each data set. The comparison made with the HEAT matrix showed that the substitutions in the divergent data sets (neutralAH/BH) deviate further from HEAT than those in the Swiss-Prot polymorphism data set, explaining the greater prediction accuracy when using the former (~20% OE) compared with the latter (28.42% OE) as neutral data. The divergent data sets are also easier to separate from disease due to their MNM (Fig. 1) , which are almost completely absent in the Swiss-Prot (polymorphism/disease) data sets. These are effectively 'easy' predictions as the DT can correctly classify ~10% of the divergent (SI90) data set on these alone.
'PSSM only' encodes position specific evolutionary information and leads to OE ranging from 26.17% -35.93%, with the T4 lysozyme proving the hardest to classify and the diseaseDivergent the easiest. The OE for the 'AA substitution only' attribute ranges from 26.06% -41.46%, a larger range than for PSSM, yet for the diseaseDivergent data sets the 'AA substitution only' is the most accurate single attribute. 'Scorecons only' is an alternative measure of position specific evolutionary information and gives rise to overall errors in the range 29.27% -36.51%. By contrast with the PSSM, scorecons encodes only conservation while the PSSM contains information on the likelihood of specific amino acid substitutions, yet this only makes a significant difference to the OE in the cases of the diseaseDivergent data sets.
The clear interpretation emerging from these observations, and the previous data set analysis, is that the simplest attribute, AA substitution, contains useful information to separate all data sets, and is highly predictive when the divergent data set is used for Table 2 . Homogenous cross-validation. Showing the average false positive rate (FPR), false negative rate (FNR) and overall-error (OE) for 10 fold crossvalidation trained on 'All' attributes, 'PSSM only', 'AA substitution only' and 'Scorecons only'. negative data (diseaseN(A/B)H in Table 2 ). Nevertheless this should be viewed with substantial caution, since, as previously noted, the effect may not be due to distinguishing deleterious from neutral mutations as distinguishing data sets differing in content of AA substitutions, owing to variations in evolutionary distance and systematic mutation. Fig. 3 shows the effect upon overall accuracy of homogeneous cross-validation (disease/divergent) when changing the minimum SI level for accepting homologs in the divergent data sets (neutralAH/BH). Using 'All' attributes produces the highest accuracy, followed by 'AA substitution only' and then 'PSSM only'. Again these results are strongly influenced by data set content. As the SI level increases the level of MNM (Fig. 1) decreases, and the divergent data sets share more similarity with the Swiss-Prot disease data set, thus increasing the observed error rate for the 'AA substitution only' attribute. In addition the 'AA substitution only' attribute is little affected by the method used to create the divergent data set. In contrast the 'PSSM only' attribute is strongly affected, with a larger variation in the OE for the neutralAH (4.06%) compared to the neutralBH (1.45%).
To optimize the generation of divergent data sets, we note that with increasing SI levels the discrepancy between the errors for the two divergent data sets diminishes, but the neutralBH gives consistently lower error rates. With 'All' attributes, lower apparent error rates result from data sets at lower SI thresholds. However, this is again misleading. It is unlikely that these data sets give better SNP classification methods, rather, the lower error rates are artefacts caused by different data set contents in terms of AA substitutions. The effect is clear with 'AA substitution only', but when 'PSSM only' is used the trend of error rate increasing with SI disappears. Both 'AA substitution only' and 'PSSM only' show a small increase in error between SI values of 90% and 95%, suggesting that if these data sets were to be used to train methods, a 90% cut-off would be preferred. This may be caused by limited data available at very high sequence identity.
Heterogeneous cross-validation
Heterogeneous cross-validation measures the ability of a classifier trained on one data set to predict on another. Table 3 shows the results for heterogeneous and homogeneous (on the diagonal) cross-validation for a selection of attributes, along with their corresponding average error rates per attribute type. In addition, for each attribute the average deviation from the homogeneous overall-error is shown, indicating how well the homogeneous cross-validation gauges predictive ability on other data sets.
First, considering 'All' attributes it is clear that error rates in heterogeneous cross validation are generally significantly higher than the corresponding values for the homogeneous case. This would be expected, but is an important effect in a field where training data can be substantially different to the final target data for prediction. An exception is that training on diseasePoly data has a homogeneous OE of 28% but predicts on diseaseNBH90 with OE of 24%. The explanation here is that this latter data set is easier to separate, for reasons previously discussed. Otherwise, transfer of rules derived from one data set results in significantly larger error rates, and perhaps most notably rules learned from the LacLyso data tend to transfer poorly to the other data sets, and vice versa. Rules based on this systematic mutagenesis data may be a poor choice for SNP prediction, and the most likely cause of this is that the AA substitution content of the data set, particularly the large level of MNMs, leads to rules of little relevance for human SNPs.
In contrast, rules derived from the other two data sets are more interchangeable, as might be expected since they share the same deleterious (disease) data. As before differences between these data sets stem from the relationship of the attributes used, to basic differences in AA substitution content in the neutral data. Notably, using 'AA substitution only', a homogeneous OE of 26% is obtained for diseaseNBH90, while the same DT rules have an OE almost 12% higher on the diseasePoly data.
It is interesting, yet intuitive, that when prediction methods are based purely on the evolutionary attributes they tend to transfer better between the different data sets. Compared with the 12% difference noted above for 'AA substitution only', with 'PSSM only' the error rate rises by only 7% between homogeneous crossvalidation (diseaseNBH90) and heterogeneous cross-validation (tested on diseasePoly). Similarly, with 'Scorecons only' the OE rises by only 3%. These attribute-dependent effects are also clear in the figures for average deviation from homogeneous OE, showing smaller deviations for the evolutionary attributes. It is also apparent that 'PSSM only' is a better predictor in general than 'Scorecons only'; the latter only encodes conservation while the former contains information about possible neutral residue replacements.
DISCUSSION
It is an appealing idea to use data from gene mutations, known to cause disease or affect protein function, to train machine learning methods for predictions on observed human nsSNPs. It is nevertheless vitally important to consider the selection of training data very carefully. In this paper we have shown that the choice of training data has significant effects on classifiers and estimated error rates.
Our results suggest that the use of mutagenesis data, with a significantly higher content of MNMs than would be expected for nsSNPs, may lead to largely irrelevant rules for SNP predictions. They remain, however, good unbiased data sets for the prediction of the effects of general protein mutations. Equally, the generation of neutral data from pseudo-mutations between orthologous proteins (divergent data set), produces data sets that can be distinguished from known disease mutations at reasonable error rates, solely on the basis of the amino acid substitutions. But such classifiers are unlikely to perform with the same low error rates in distinguishing human deleterious and neutral SNPs. The rules may have some predictive power for SNPs, but a significant contribution to their apparent homogeneous cross-validation accuracy results from separation of the training data on the basis of content of amino acid substitutions, caused by different evolutionary distances in the deleterious and neutral parts of the training data. One potential way of improving the divergent data sets is to limit the aligned orthologous proteins to primates, thus, reducing the evolutionary distance. This results in a neutral data set that has a higher correlation with HEAT (r = 0.81, p < 0.0001) than the mammalian derived data set (NBH90; r = 0.74, p < 0.0001) yet still much lower than the Swiss-Prot polymorphism (r = 0.91, p < 0.0001). When combined with Swiss-Prot disease this new neutral data set produces a homogeneous OE of 23.23%, placing it between diseaseNBH90 (OE 19.88%) and diseasePoly (OE 28.42%). Thus, while this data set is closer to HEAT than NBH90 it is still clearly over a longer evolutionary distance than the Swiss-Prot polymorphism data. Therefore, we suggest that the best training data for human nsSNP predictions is the Swiss-Prot annotated 'disease' and 'polymorphism' variants of known human proteins. This is not without problems: variants annotated as neutral polymorphisms may have an unknown association with disease. Nevertheless the differences in Figures 2B and 2C , and the fact that learning methods can successfully separate disease and polymorphism classes, suggests that this is unlikely to be the case for the majority of the data.
Equally it might be suggested that other data sets could be used if appropriate attributes were chosen. Rules based on evolutionary attributes are more transferable between data sets than AA substitutions. However, any good learning method will separate the data sets using the most informative attributes, and it can be difficult to completely remove effects such as those reported here. For instance, the apparently purely physicochemical attributes hydrophobicity and molecular-mass-difference contain information sufficient to identify the AA substitution involved. Such effects are even harder to tease out with methods less interpretable then decision trees (e.g. support vector machines or neural networks). The training data is fundamental, it affects all methods and it is important to get it right first.
CONCLUSIONS
We have raised some important issues regarding training data for nsSNP prediction methods and recommended a best data set (Swiss-Prot disease/polymorphism). We believe that effects described here have affected several studies, including our own, and whatever view is taken on the best data set it is important that workers in the field be aware of them.
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